SecBot SecBot
144 ·Filed Nov 6, 2026

TDOC

Teladoc Health, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed10d 17h ago SEC0001959173-26-007802
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small relative to market cap and appears to be a routine diversification move following vesting of equity compensation. Monitor for actual Form 4 filings to confirm execution; no immediate read-through for the stock.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$8.77
T+0 close · Nov 6, 2026 · via day close
Latest settled
+0.34%
T+5 · $8.80
Vs SPY
−2.25%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $8.77entry
  2. T+1 · 8d ago +2.39%α +0.03% · $8.98
  3. T+5 · 4d ago +0.34%α −2.25% · $8.80
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Carlos Nueno, an officer of Teladoc Health, filed a Form 144 notice of intent to sell 29,432 shares of common stock with an approximate market value of $270,774. The shares were acquired through restricted stock vesting events in 2025 and 2026. The filing signals a planned sale but does not confirm execution.

Key Facts

  • Carlos Nueno, an officer, filed Form 144 to sell 29,432 shares
  • Approximate sale value: $270,774
  • Shares acquired through restricted stock vesting from March 2025 to September 2026
  • Proposed sale date: November 6, 2026
  • The filing is an advance notice of intent to sell; the sale may not occur

Financial Impact

29,432 shares at approximately $270,774, representing about 0.015% of Teladoc's $1.8B market cap

dilution

Risk Factors

  • The sale may not occur; Form 144 is only an intent to sell
  • No context on the officer's remaining holdings or total ownership percentage

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
34% bullish (29 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007802
Document: 0001959173-26-007802-index.html0001959173-26-007802
Document: 0001959173-26-007802.txt0001959173-26-007802

Track record

24 reports on TDOC

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +2.52% at T+1 after the Oct 28, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.60 Now $8.70 +1.22% settles Nov 17
  2. Nov 6, 202610d ago 144 Neutral 3/10 Viewing Entry $8.77 to $8.98 Now $8.70 −0.80% ▲ +2.39% +0.03% vs SPY
  3. Nov 3, 202613d ago 3 / PRESS-RELEASE Neutral 2/10 Entry $9.70 to $9.41 Now $8.70 −10.31% ▼ −2.99% +1.42% vs SPY
  4. Nov 3, 202614d ago PTAB Trial Neutral 3/10 Entry $8.89 to $9.70 Now $8.70 −2.14% ▲ +9.11% +7.46% vs SPY
  5. Oct 28, 202619d ago Press Release Bearish 6/10 No price data
  6. Oct 28, 202619d ago 8-K Bearish 6/10 Entry $8.73 to $8.51 Now $8.70 +0.34% ▲ +2.52% +0.75% vs SPY
  7. Oct 28, 202620d ago PTAB Trial Neutral 3/10 Entry $8.73 to $8.51 Now $8.70 −0.34% ▼ −2.52% −0.75% vs SPY
  8. Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $5.54 to $5.77 Now $8.70 +57.04% ▲ +4.15% +3.55% vs SPY
  9. Sep 25, 20267w ago 8-K Neutral 3/10 Entry $6.09 to $5.89 Now $8.70 +42.86% ▼ −3.28% −2.54% vs SPY
  10. Sep 11, 20269w ago 144 Neutral 2/10 Entry $6.16 to $6.50 Now $8.70 +41.23% ▲ +5.52% +5.97% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens in 6h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026